Lymphatic Malformations - 26 Studies Found
Terminated |
: Selenium in the Treatment of Complicated Lymphatic Malformations : Lymphatic Malformations : 2010-09-24 : Drug: Selenium 400 μg once a day for 6 months by mouth |
Completed |
: Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations : Lymphatic Malformations : 2001-02-02 : Drug: picibanil Up to .2 mg per injection, given intralesionally every 6-8 weeks |
Completed |
: A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations : Lymphangioma : 2011-02-03 : Drug: Sildenafil Sildenafil oral tablet three times daily |
Recruiting |
: Sildenafil for the Treatment of Lymphatic Malformations :
: 2015-01-07 :
|
Active, not recruiting |
: Airway Vascular Lesions :
|
Recruiting |
: Lymphatic Anomalies Registry :
: 2015-03-17 |
Completed |
: Diagnosis of Hemangiomas and Vascular Malformations :
|
Active, not recruiting |
: Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies :
|
Completed |
: Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options. : Vascular Anomalies : 2005-12-02 : Drug: Marimastat |
Completed |
: Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions : 22q11.2 Deletion Syndrome : 2016-08-29 : Drug: NFC-1 Doses of NFC-1 will be administered as 50, 100, 200, or 400 mg twice daily as size 2, hard g |